Medicamen Biotech Limited (MEDICAMEQ.NS)
INR 557.3
(0.3%)
INR 557.3
(0.3%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 7.50 INR | -37.08% |
| 2022 | 11.92 INR | -2.21% |
| 2021 | 12.19 INR | 22.76% |
| 2020 | 9.93 INR | -8.73% |
| 2019 | 10.88 INR | 5.84% |
| 2018 | 10.28 INR | 13.84% |
| 2017 | 9.03 INR | 82.42% |
| 2016 | 4.95 INR | 931.25% |
| 2015 | 0.48 INR | -2.04% |
| 2014 | 0.49 INR | 345.45% |
| 2013 | 0.11 INR | 101.87% |
| 2012 | -5.88 INR | -465.38% |
| 2011 | -1.04 INR | -128.97% |
| 2010 | 3.59 INR | -30.29% |
| 2009 | 5.15 INR | 189.33% |
| 2008 | 1.78 INR | -9.18% |
| 2007 | 1.96 INR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 1.06 INR | -36.9% |
| 2023 Q4 | 1.68 INR | 5.0% |
| 2023 FY | - INR | -37.08% |
| 2023 Q1 | 3.30 INR | 7.49% |
| 2023 Q2 | 1.20 INR | -63.64% |
| 2023 Q3 | 1.60 INR | 33.33% |
| 2022 Q1 | 2.94 INR | 30.67% |
| 2022 Q2 | 2.85 INR | -3.06% |
| 2022 Q4 | 3.07 INR | 3.02% |
| 2022 FY | - INR | -2.21% |
| 2022 Q3 | 2.98 INR | 4.56% |
| 2021 Q4 | 2.25 INR | -27.18% |
| 2021 FY | - INR | 22.76% |
| 2021 Q2 | 3.46 INR | 1.76% |
| 2021 Q1 | 3.40 INR | 13.71% |
| 2021 Q3 | 3.09 INR | -10.69% |
| 2020 Q4 | 2.99 INR | 21.05% |
| 2020 Q1 | 1.84 INR | -9.8% |
| 2020 Q3 | 2.47 INR | -6.44% |
| 2020 Q2 | 2.64 INR | 43.48% |
| 2020 FY | - INR | -8.73% |
| 2019 Q3 | 3.05 INR | -4.09% |
| 2019 Q4 | 2.04 INR | -33.11% |
| 2019 FY | - INR | 5.84% |
| 2019 Q1 | 2.75 INR | 15.55% |
| 2019 Q2 | 3.18 INR | 15.64% |
| 2018 Q4 | 2.38 INR | 15.53% |
| 2018 FY | - INR | 13.84% |
| 2018 Q3 | 2.06 INR | -32.46% |
| 2018 Q2 | 3.05 INR | 10.91% |
| 2018 Q1 | 2.75 INR | 72.96% |
| 2017 Q2 | 2.42 INR | 6.14% |
| 2017 Q1 | 2.28 INR | 117.14% |
| 2017 Q3 | 2.49 INR | 2.89% |
| 2017 Q4 | 1.59 INR | -36.14% |
| 2017 FY | - INR | 82.42% |
| 2016 Q2 | 1.16 INR | 1.75% |
| 2016 FY | - INR | 931.25% |
| 2016 Q4 | 1.05 INR | -36.75% |
| 2016 Q3 | 1.66 INR | 43.1% |
| 2016 Q1 | 1.14 INR | -37.7% |
| 2015 Q3 | -1.47 INR | -476.92% |
| 2015 FY | - INR | -2.04% |
| 2015 Q1 | -0.26 INR | -3980.6% |
| 2015 Q2 | 0.39 INR | 250.0% |
| 2015 Q4 | 1.83 INR | 224.49% |
| 2014 Q4 | 0.01 INR | 101.63% |
| 2014 Q1 | 0.34 INR | 165.38% |
| 2014 Q2 | 0.56 INR | 64.71% |
| 2014 Q3 | -0.41 INR | -173.21% |
| 2014 FY | - INR | 345.45% |
| 2013 Q4 | -0.52 INR | -4.0% |
| 2013 Q3 | -0.50 INR | -183.33% |
| 2013 Q1 | 0.54 INR | 135.76% |
| 2013 Q2 | 0.60 INR | 11.11% |
| 2013 FY | - INR | 101.87% |
| 2012 Q3 | -2.02 INR | -38.36% |
| 2012 Q2 | -1.46 INR | -52.08% |
| 2012 Q1 | -0.96 INR | -132.43% |
| 2012 FY | - INR | -465.38% |
| 2012 Q4 | -1.51 INR | 25.25% |
| 2011 Q2 | -2.91 INR | 0.0% |
| 2011 Q4 | 2.96 INR | 344.63% |
| 2011 FY | - INR | -128.97% |
| 2011 Q3 | -1.21 INR | 58.42% |
| 2010 FY | - INR | -30.29% |
| 2009 FY | - INR | 189.33% |
| 2008 Q4 | -1.25 INR | 0.0% |
| 2008 FY | - INR | -9.18% |
| 2007 Q4 | 0.79 INR | 0.0% |
| 2007 FY | - INR | 0.0% |